In a groundbreaking decade-long study analyzing São Paulo’s urban landscape, researchers have revealed how the expansion of bike lanes and public parks profoundly influences physical activity and public health. Between 2014 and 2024, the city’s bike lane network surged from 242 to 743 kilometers, complemented by the addition of 15 municipal parks. This urban transformation was linked to increased transport-related cycling, emphasizing the critical role of accessible infrastructure within a 500-meter radius of residents’ homes.

The study’s multidisciplinary approach combined longitudinal surveys of 1,500 residents with geospatial datasets from the Geosampa platform, enabling precise correlation between environmental changes and behavior. Findings indicate that proximity to bike lanes significantly counteracts declining bicycle use trends, suggesting these facilities serve as protective factors promoting sustained physical activity. Such activity reduction directly translates to lower risks of cardiovascular disease, cancer, and improved mental health outcomes like reduced anxiety and depression.

Importantly, the research underscores active transportation infrastructure not only as a logistical planning tool but as a vital public health strategy. By reducing reliance on automobiles, these interventions diminish air pollution and traffic-related accidents, thereby contributing to climate change mitigation efforts. However, the study highlights uneven developments: wealthier neighborhoods received disproportionate infrastructure investments, calling for policy shifts to equip underserved zones with similar amenities.

Beyond infrastructural improvements, the researchers emphasize that sociocultural elements and affordability constraints also limit cycling uptake. Despite increased bike lanes, economic barriers such as the high cost of bicycles and gender disparities in cycling participation suggest that integrated approaches—encompassing recreational street design, bike-sharing expansions, and commuter support facilities—are necessary for meaningful behavioral shifts.

An illustrative testimony comes from a local photographer who transitioned from motorbike to bicycle commuting due to new bike bridges providing direct, safer routes. While embracing cycling’s growth, he voices concerns about road space allocation favoring cars and the emerging challenges of cyclists’ vulnerability amid the rise of faster electric bikes. Additionally, issues of public safety and bike theft remain barriers to broader adoption.

Overall, the findings reveal that São Paulo’s urban planning efforts over the past decade represent a promising model of how thoughtfully designed public open spaces can foster healthier, more sustainable cities. Still, ensuring equitable access and addressing multifaceted cultural and socioeconomic factors remain essential for realizing the full potential of active transport systems.

---

Subject of Research: Public open spaces and transport-related cycling in urban environments
Article Title: A decade-long study on public open spaces and transport-related cycling in the largest Brazilian city
News Publication Date: 13-Apr-2026
Web References: https://dx.doi.org/10.1016/j.jth.2026.102323
Image Credits: Phelipe Janning/Agência FAPESP

Keywords

Urban planning, Transportation, Public health, Cycling, Active transportation, São Paulo, Infrastructure, Mental health

Chromosome instability and aneuploidy have long posed a conundrum in cancer biology, profoundly shaping tumor genomes yet remaining challenging to decode functionally. In a groundbreaking study published in Nature, Al-Zahrani et al. unveil a novel approach, CRISPR-KOALA, that systematically links large-scale chromosomal alterations to specific cancer-driving genes in basal-like breast cancer (BLBC).

BLBC, a highly aggressive subtype characterized by extensive copy-number alterations (CNAs), often harbors arm-level chromosomal imbalances whose contribution to tumorigenesis remains elusive. The researchers developed CRISPR-KOALA to conduct high-throughput bidirectional genetic screens directly in immunocompetent mouse models, overcoming previous barriers related to the complexity and scale of genes affected by aneuploidy.

By focusing on the ten most frequent human chromosome-arm alterations seen in BLBC, the team screened over 3,700 mouse orthologues of genes located on these arms. The screen identified 90 putative cancer driver genes—a majority of which had not been previously linked to cancer—revealing a diverse functional landscape shaping tumor biology. Among the implicated pathways were key signaling networks such as MAPK, HIPPO, and WNT, highlighting the heterogeneity intrinsic to BLBC progression.

Strikingly, manipulating these driver genes in Trp53-mutant mouse models was sufficient to bypass the need for whole-arm CNAs, suggesting that tumors exploit specific genes within broad chromosomal alterations to fuel oncogenesis. This finding challenges the traditional view that arm-level aneuploidies function merely as genomic chaos, instead presenting them as evolutionary selections for particular drivers.

One gene, PLGRKT, localized on chromosome 9p, emerged as a potent oncogene. The team showed that PLGRKT promotes tumor growth by enhancing mitochondrial robustness and boosting reactive oxygen species detoxification. This mechanistic insight connects chromosomal instability not only to genetic selection but also to metabolic adaptations that support cancer cell survival under stress.

Overall, this study delivers a transformative platform and a compendium of cancer drivers that illuminate how aneuploidy sculpts tumor heterogeneity. By delineating driver genes nested within widespread CNAs, it provides an invaluable resource for targeting breast cancer’s genetic complexity with greater precision.

The implications extend beyond breast cancer, offering a blueprint for dissecting arm-level aneuploidy in diverse malignancies. As cancer therapies increasingly focus on genetic vulnerabilities, CRISPR-KOALA represents a leap toward untangling the intricate link between chromosome-level alterations and oncogenic processes.

This work underscores the power of integrating genomic data with functional genetics in vivo, setting the stage for novel drug targets and therapeutic strategies aimed at the underexplored realm of aneuploidy-driven tumorigenesis.

---

Subject of Research: Chromosome instability and cancer driver genes in basal-like breast cancer

Article Title: Aneuploidy selects for the acquisition of driver genes in breast cancer

Article References:
Al-Zahrani, K.N., Langille, E.R., Nurtanto, J. et al. Aneuploidy selects for the acquisition of driver genes in breast cancer. Nature (2026). https://doi.org/10.1038/s41586-026-10752-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41586-026-10752-9

A groundbreaking imaging technology developed by researchers at the University of Oklahoma promises to revolutionize liver transplant evaluations by enabling more comprehensive and rapid assessments of donor organ health. With thousands of patients awaiting liver transplants nationwide, transplant teams urgently need tools that can deliver swift, accurate insights without invasive procedures. The team, led by Dr. Qinggong Tang, has adapted polarization-sensitive optical coherence tomography (PS-OCT)—an advanced imaging modality originally utilized in retinal scans—to noninvasively evaluate donor livers at high resolution.

Traditional liver assessments rely heavily on biopsies, where small tissue samples are extracted and examined for signs of disease or damage. While considered the gold standard, biopsies are inherently limited, providing only a microscopic snapshot of a vast organ that may vary in condition. This narrow sampling can cause uncertainty, sometimes leading to the discard of viable organs. The OU team sought to overcome these limitations by employing PS-OCT, which not only captures detailed cross-sectional images of liver tissue but also measures its polarization properties, revealing subtle structural and biochemical features linked to liver health.

The engineers designed a portable PS-OCT system optimized for clinical and operating room environments, allowing transplant teams to scan liver surfaces quickly and noninvasively. The imaging data are then analyzed using advanced artificial intelligence algorithms, co-developed with Dr. Chongle Pan’s computer science lab. These AI tools quantify critical parameters indicative of hepatic steatosis (fat accumulation) and inflammation, two primary factors influencing liver viability. By training their models on datasets from over thirty clinical cases—comparing PS-OCT results with biopsy outcomes and post-transplant organ function—the researchers demonstrated strong correlations between imaging biomarkers and actual clinical metrics.

Beyond providing a more holistic view of donor liver condition, PS-OCT could enhance decision-making speed, potentially expanding the pool of organs deemed suitable for transplantation by identifying healthy tissue regions missed by biopsy. Such improvements may reduce organ discard rates and improve transplant success. Encouraged by initial findings, the OU team plans a large multisite clinical trial involving institutions like UT Southwestern and the Cleveland Clinic to validate and refine this approach across diverse patient populations.

This work exemplifies OU’s interdisciplinary innovation platform that integrates optical bioimaging, machine learning, pathology, and organ perfusion technology to translate engineering advances directly into clinical practice. The researchers also intend to extend PS-OCT evaluation methods to other organs, including kidneys and lungs, widening the impact of this technology.

Supported by National Science Foundation grants and institutional partnerships, the team’s efforts mark a significant step toward redefining how transplanted organs are assessed. Dr. Tang emphasizes that this is just the beginning, envisioning a future where noninvasive, AI-enhanced imaging facilitates safer, faster, and more effective organ transplantation worldwide.

---

Subject of Research: Donor liver evaluation using advanced imaging techniques
Article Title: Human donor liver viability evaluation with polarization-sensitive optical coherence tomography
News Publication Date: 24-Jun-2026
Web References: http://dx.doi.org/10.1126/scitranslmed.adv7124
Image Credits: University of Oklahoma / Ellie Pinter

Keywords

Organ transplantation, Optical coherence tomography, Polarization-sensitive imaging, Liver viability, Artificial intelligence, Biomedical imaging, Noninvasive diagnostics, Medical innovation

In a groundbreaking fusion of cutting-edge technology and dermatological research, scientists at Biohub have unveiled novel therapeutic targets for psoriasis by conducting the first comprehensive genome-wide CRISPR screen in primary human adult skin cells. By overcoming the longstanding technical hurdle of delivering CRISPR components into notoriously resistant keratinocytes without toxicity, the team utilized centrifuge-based transfection to probe the genetic regulators involved in psoriasis, a chronic inflammatory skin disorder affecting millions globally.

This innovative approach involved knocking out approximately 19,000 genes in keratinocytes sourced from human donors using a vast CRISPR guide RNA library. The focus was on modulating IL17RA, a pivotal receptor that mediates skin inflammation, to chart a genome-wide landscape of genes influencing inflammatory pathways directly in the skin’s outermost layer. The resultant massive data set was then mined using an AI-driven model, VirtualCRISPR, which cross-referenced each gene’s significance against existing scientific literature to highlight previously unrecognized contributors to psoriasis pathology.

Strikingly, this AI-guided screen pinpointed two promising protein targets: ALOX5, an enzyme targeted by the asthma medication zileuton, and OXTR, the gene encoding for the oxytocin receptor, a surprising candidate unassociated before with skin inflammation. Validation experiments in 3D reconstructed human skin cultures demonstrated that zileuton modulates keratinocyte metabolism to suppress inflammation independently from immune cells, revealing a direct pharmacological avenue.

Importantly, topical formulations containing zileuton and cligosiban, an OXTR antagonist, were tested in a mouse model of psoriasis, achieving comparable efficacy to standard injected biologics that broadly suppress immune function. Beyond mitigating inflammation, OXTR inhibition appeared to restore skin barrier integrity—a crucial factor in chronic disease progression—spotlighting this receptor as a novel therapeutic axis.

Unlike current systemic therapies, which often carry risks of broad immunosuppression and high costs, these localized topical interventions promise targeted treatment with minimal systemic exposure. Moreover, the safety profiles of zileuton and OXTR antagonists are well-established in clinical settings, potentially accelerating their repurposing for dermatological applications.

This study exemplifies the transformative power of integrating AI with high-dimensional genetic screening to unravel complex disease mechanisms in cell types previously inaccessible to large-scale functional genomics. By enabling direct investigation into keratinocyte biology, the research not only charts a course for new psoriasis treatments but also sets a precedent for applying similar methodologies to other inflammatory conditions.

As psoriasis affects roughly 125 million people worldwide, innovations enabling precise, effective, and safer therapies could revolutionize patient care. Biohub’s approach heralds a new era where AI-guided CRISPR screens expedite the discovery of unexpected drug targets and foster the development of locally acting, biology-informed treatments.

---

Subject of Research: Psoriasis therapeutic targets via genome-wide CRISPR screening of human skin cells

Article Title: AI-guided CRISPR screening reveals therapeutic targets in psoriasis

News Publication Date: 8-Jul-2026

Web References:
https://www.nature.com/articles/s41467-026-75249-5

References:
DOI: 10.1038/s41467-026-75249-5

Image Credits: Biohub

Keywords

Psoriasis, CRISPR, Oxytocin receptor, ALOX5, Zileuton, Cligosiban, Keratinocytes, AI-guided screening, Inflammation, Topical therapeutics

A groundbreaking study unveils how the ARP2/3 complex orchestrates the dynamic behavior of neurites, providing fresh insights into neuronal growth and polarity. Researchers utilized advanced optogenetic tools to manipulate RAC1, an upstream regulator of ARP2/3, revealing spatially distinct roles of actin assembly in neuronal morphology.

By employing photoactivatable RAC1 (PA-RAC1), the team demonstrated that ARP2/3-mediated actin assembly at neurite tips promotes growth cone activation and neurite extension. Local activation of PA-RAC1 triggered robust growth cone dynamics, driving neurite elongation. Conversely, activation of a dominant-negative RAC1 mutant led to collapse of the growth cone and neurite retraction, underscoring ARP2/3’s role in sustaining neurite advancement.

Intriguingly, PA-RAC1 activation at the soma induced lamellipodia formation reminiscent of nascent actin waves, which were associated with neurite retraction events. This phenomenon mirrored intrinsic cellular behaviors where somatic actin waves correspond with retracting neurites. The study elegantly showed that the emergence of these waves reduced somatic actin patch intensity, indicating a tightly regulated cytoskeletal oscillator mechanism.

The authors further explored the effects of ARP2/3 inhibition using CK-666 perfusion at distinct cellular locales. When applied over the soma and proximal neurites, CK-666 induced neurite retraction, whereas neurites outside this region continued growing unabated. Notably, actin waves were initiated in neurites outside the inhibited zone, propagating retrogradely toward the soma but dissipating upon entering CK-666-exposed areas. This highlights a spatial dependence of ARP2/3 activity for wave initiation and propagation.

Remarkably, simultaneous activation of PA-RAC1 at multiple growth cones revealed competitive dynamics in actin assembly, with enhanced growth cone activity limited to one or two sites. This suggests an intrinsic cellular mechanism balancing cytoskeletal resources and neurite growth across the complex neuronal arborization.

Together, these findings articulate a dual role for ARP2/3: driving actin wave initiation at the soma that triggers neurite retraction, and supporting growth cone expansion at neurite tips to promote extension. This oscillatory interplay mediated by ARP2/3 and RAC1 underscores the cytoskeleton’s fundamental role in establishing neuronal polarity.

This study not only provides a mechanistic framework for how neurons spatially regulate growth and retraction but also suggests that intrinsic cytoskeletal oscillators underpin the dynamic remodeling necessary for proper neuronal circuit formation. These insights pave the way for future investigations into cytoskeletal dysregulation in neurodevelopmental disorders and neuronal regeneration strategies.

The precise spatial control of actin dynamics mediated by ARP2/3 complex activity advances our understanding of neuronal development, highlighting how local cytoskeletal modulators can dictate overall neuronal architecture through oscillatory growth behaviors.

---

Subject of Research: Neuronal cytoskeletal dynamics and polarity establishment

Article Title: An intrinsic cytoskeletal oscillator establishes neuronal polarity

Article References:
Lin, Tc., Coles, C.H., Alfadil, E. et al. An intrinsic cytoskeletal oscillator establishes neuronal polarity. Nature (2026). https://doi.org/10.1038/s41586-026-10755-6

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41586-026-10755-6

The extreme heat smothering Europe has upended Climate Week in London.

© Pool photo by Yui Mok

The government is teaming up with Colossal Biosciences, a private company that claims to have revived extinct dire wolves, to store samples from at-risk animals and plants.

© Lenny Ignelzi/Associated Press

Cancer has a dirty trick: it can put itself to sleep. When tumor cells slip into a kind of biological hibernation, they become hard to kill, shrugging off treatment and lying low until conditions improve, then waking up and bringing the disease back. For decades, researchers have struggled to shut down this hiding strategy without causing serious harm elsewhere in the body. A team in Switzerland has now built a molecule that flips on and off with flashes of light, giving scientists a precise new way to probe, and possibly disrupt, the way sleeping cancer cells hide.

Behind this cellular sleep state, at least in certain cancers, sits a protein called the glucocorticoid receptor, a sensor inside cells that reacts to stress hormones. When it switches on, it can push cancer cells, especially in some solid tumors such as lung cancer, into a drug-resistant, dormant state. The obvious fix would be to destroy the receptor outright, but there is a catch: the same receptor does important jobs all over the body, including calming inflammation. Removing it everywhere would cause real damage. What was needed was a way to hit the receptor inside a tumor and leave the rest of the body alone.

That is what the team set out to build. Their solution, described in the journal Proceedings of the National Academy of Sciences, is a class of molecules called photoPROTACs: drug-like compounds engineered to destroy the stress hormone receptor, but only when a specific color of light switches them on. Shine the right light on them, and they go to work. Keep them in the dark, and they stay idle.

A Kill Switch for a Stress Hormone Receptor

It helps to know what a PROTAC is. A PROTAC is a molecule that grabs onto a specific protein inside a cell and tags it for destruction by the cell’s own waste-disposal system. It works like slapping a “delete me” sticky note on an unwanted protein. PROTACs have stirred huge excitement in medicine because they can eliminate proteins that ordinary drugs cannot touch.

Conventional PROTACs have a problem: they are always on. Once taken, they work throughout the entire body, destroying their target in cancer cells and healthy cells alike. For a receptor this important to normal health, that is a dealbreaker.

To get around it, the team embedded a light-sensitive part directly into the PROTAC molecule. By adding a chemical structure that physically changes shape depending on the wavelength of light hitting it, they created a molecular switch. In one shape, called the E-form, the molecule has the right geometry to do its job and destroy the receptor. In the other, the Z-form, it bends into a configuration that leaves it far less active. The switch runs both ways: one wavelength turns the molecule on, another turns it off.

Building the Light-Activated Cancer Switch

Researchers built and tested several versions of these light-switchable molecules, hunting for the best balance of stability and responsiveness. Two lead compounds, KH-5-306 and KH-5-309, stood out. Both flipped almost completely between their active and inactive shapes under different wavelengths of light and showed no signs of wearing out after repeated exposure.

Inside cells, both compounds destroyed the stress hormone receptor in their active E-form at very low doses. Switched to the inactive Z-form, the effect dropped sharply, though the inactive form still held on to some activity. Because the Z-form naturally drifts back toward the active E-form at body temperature, researchers kept it locked in place during experiments by hitting the cells with brief bursts of ultraviolet light every 30 minutes, a lab-only workaround they confirmed did not harm the cells or disturb the biology under study, and not a method meant for patients.

Additional tests confirmed the receptor destruction ran through the cell’s normal disposal machinery: when a separate inhibitor blocked that machinery, the photoPROTACs stopped working. The compounds also left a closely related receptor alone, even at higher doses, a sign the molecules were hitting their intended target and not damaging look-alikes. And the effect proved temporary. When the active compound was washed away after 12 hours, receptor levels started climbing back within 24.

Waking Up Sleeping Lung Cancer Cells

With the chemistry checked, researchers moved to a test closer to real medicine. They took human lung cancer cells and treated them with dexamethasone, a common steroid that switches on the glucocorticoid receptor and nudges these cells into a dormancy-like state. That setup mirrors a real problem: dexamethasone is routinely given to cancer patients to manage inflammation and treatment side effects, yet it may quietly push tumor cells toward this drug-resistant sleep.

After confirming that dexamethasone triggered the expected dormancy response, the team tested whether the lead photoPROTAC, KH-5-309, could reverse it. Cells treated with the active E-form saw the dormancy-linked gene activity roll back toward normal, and a sweep across thousands of genes confirmed the shift toward a more active state. By contrast, the inactive Z-form left those genes essentially untouched, behaving in this experiment as a neutral control on par with no treatment at all.

What’s Next for Light-Controlled Cancer Treatment

Researchers are candid about the limits. The biggest obstacle to reaching real patients is the kind of light involved. The wavelengths that switch these compounds on do not travel far into living tissue, so the current version could not reach a tumor buried deep in the body. Developing compounds that respond to longer, redder wavelengths, such as near-infrared light that penetrates tissue more deeply, is a key goal for future work rather than a solved problem.

For now, the strongest promise is in the lab: studying cancer biology in cell cultures, tissue slices, and lab-grown miniature organs called organoids, where light can be aimed precisely and repeatedly. Those tools give scientists a way to study how stress hormone signaling drives cancer behavior that existing drugs cannot match.

Cancer’s ability to play dead has long been one of the most frustrating barriers to lasting cures. This is early-stage work, years from any use in the clinic, but a well-aimed flash of light that disrupts cancer’s hiding strategy is the kind of proof-of-concept result that hands researchers a fresh grip on a stubborn problem.

Read full story here…

Scientists claim that for the first time in history, they have constructed a synthetic cell that feeds, grows, and replicates — just like a natural one — out of non-living chemical components.

The team from the University of Minnesota says their “SpudCell” is the “first synthetic cell with a complete cell cycle,” and can “grow, replicate its genome, divide, and undergo selection and competition across multiple generations.”

The research, which is being hailed as a major breakthrough, could usher in a new biotech era defined by synthetic organisms that can be grown from scratch and programmed to complete specific functions. It’s a futuristic approach that could open many doors for our efforts to solve a wide variety of human problems, from fighting cancer to capturing carbon.

It could also challenge our preconceived notions of what’s considered “life,” while exploring the essential functions of a living cell.

“We’ve replicated in chemistry what only used to be possible in biology: the complete set of behaviors of a cell,” said team lead and University of Minnesota synthetic biologist Kate Adamala in a statement about the work. “It proves that the most fundamental functions of life, like growth and replication, do not need a mysterious magical spark.”

Yet the research is still in its infancy. SpudCell is still primitive, most closely resembling a bacterium. But since it’s built from scratch, the team says it has some key advantages over natural cells.

“I know the full ingredient list of the cell, I know exactly what chemicals, what molecules at what concentrations,” Adamala told CNN. “It is fully defined, which means we can engineer it.”

“We’re hoping we’re really starting the true age of bioeconomy, enabling technology that will let people engineer biology,” she added.

As detailed in a preprint paper that’ll be submitted for publication this week, SpudCell is made up of anywhere from 150 to 200 molecules. While it can feed, grow and replicate across roughly five generations, it’s orders of magnitude simpler than a natural cell, which can hold billions of molecules.

Adamala called the construct an “incredibly wimpy organism that right now basically does nothing other than to eat and occasionally make a daughter cell.”

To get it to replicate once every 12 hours or so, scientists have to feed it externally while holding it at 86 degrees Fahrenheit. That’s a lot slower than natural bacteria, like E. coli, which divides every 30 minutes, as CNN points out.

It also can’t produce its own proteins, meaning that scientists have to feed it regularly.

Put simply, SpudCell is far from self-sufficient.

“It’s just the beginning,” Adamala told CNN. “It’s a chassis that we’re hoping to build on, and that’s significant, because now we actually can have some reasonable idea of how to build on it.”

Whether SpudCell actually constitutes what we refer to as “life” remains hotly debated, with experts arguing it can’t evolve on its own without the laborious care of its makers.

“I would say Kate has constructed a cell,” Stanford University associate professor of bioengineering Drew Endy, who founded a public-benefit institution alongside Adamala, told CNN. “I don’t think she’s created life.”

“However, does it promise a future where more people will be able to build cells?” he added. “Yes.”

Others were more open to the idea that the researchers had made a major step towards creating synthetic life.

“Kate Adamala’s team designed and built a nonliving synthetic cell that is much closer to being ‘alive’ than anything else produced by the bottom-up synthetic cell field,” J. Craig Venter Institute synthetic cell researcher John Glass, who was not involved in the research, told the New York Times.

Read full story here…

💾

In the realm of modern ophthalmology, Optical Coherence Tomography (OCT) has revolutionized the way eye diseases are diagnosed and monitored. This non-invasive imaging technology allows clinicians to peer through the layers of the retina, producing detailed cross-sectional images that reveal the structural integrity of this delicate tissue without the need for surgical intervention. However, despite OCT’s widespread adoption and profound clinical impact, the technology is inherently limited by physical constraints that occasionally obscure or degrade the crucial information contained within these images. The newly developed Spatio-Temporal Optical Coherence Tomography (STOC-T) promises to address these limitations by fundamentally altering data acquisition methods, thereby enhancing image quality and diagnostic precision at the earliest possible stage.

OCT functions by directing light into the eye and interpreting the backscattered photons to construct images of internal structures like the retina and choroid. But the journey of photons through tissue is fraught with challenges. When light encounters complex biological matrices, it scatters unpredictably, producing signals that blend with those carrying useful information. This phenomenon, known scientifically as “optical crosstalk,” causes image blur and loss of contrast, making it difficult to discern fine detail that could be critical for early disease detection. Optical crosstalk is essentially a breakdown of coherence within the returning light, as photons from a single spatial point arrive dispersed across multiple detector pixels. For ophthalmologists and patients alike, this translates to potentially missed or delayed diagnosis of conditions where subtle changes herald disease onset.

The breakthrough reported by Professor Maciej Wojtkowski and his team from the International Centre for Translational Eye Research (ICTER) introduces STOC-T, an innovative approach that goes beyond conventional image enhancement techniques. Unlike software filters applied post-hoc to clean up images, STOC-T reforms the optics of data collection itself—imposing controlled, repetitive phase modulations onto the illuminating light during scanning. By employing distinct spatial phase masks that alter the wavefront of the illuminating beam, the system captures a series of images, each with a differently patterned illumination. Scattered photons, which respond chaotically to these phase shifts, become decorrelated and diminish upon averaging multiple frames. Conversely, photons faithfully reflecting true tissue architecture maintain coherent behavior, thus strengthening their visibility in the final reconstructed image.

This methodology can be likened to differentiating a single voice in a bustling crowd. Just as a consistent voice can be isolated amid random background chatter using adaptive recording strategies, STOC-T distinguishes meaningful optical signals from noise in real-time. This preemptive discrimination obviates the need for computational post-processing to “clean” images after data acquisition, which historically cannot fully recover information lost to scattering. Defensive design of the imaging process ensures that interfering signals are suppressed from the outset, preserving delicate cellular-level details of the retina and choroid that are indispensable for early diagnosis.

STOC-T’s performance has been rigorously tested both in laboratory settings and on living tissue. In one compelling demonstration, a standard imaging target obscured by a highly scattering artificial medium and even by rat skin rendered virtually invisible under conventional OCT. Upon integrating STOC-T’s phase modulation technique, the obscured structural features resurfaced with remarkable clarity. This experiment underscores the scale of the optical crosstalk problem and the potency of STOC-T, since the objects remained physically present but were previously hidden by noise.

The true clinical significance comes from STOC-T’s application to human retinal imaging, where it achieves a lateral resolution near five micrometers—a scale sufficiently fine to resolve individual photoreceptors and ganglion cells as well as intricate vasculature within the choroid. This extraordinary level of detail enables prospective monitoring of microscopic disease processes with an acuity far surpassing existing OCT methods. Additionally, STOC-T provides new insights through optoretinography (ORG), capturing functional responses of photoreceptors to flickering light stimuli at frequencies up to 45 Hz. These functional measurements resemble electrophysiological studies conducted via invasive patch-clamp techniques, suggesting that STOC-T could non-invasively monitor cellular function—a significant leap for early detection of retinal dysfunction before structural damage occurs.

The potential clinical impact of this technology cannot be overstated. Visual impairment affects more than 2.2 billion individuals worldwide, with over a billion cases attributable to conditions amenable to early diagnosis and intervention. Diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration often become irreversibly severe due to delayed detection. STOC-T’s capacity to enhance diagnostic accuracy at the cellular and functional levels augments the ophthalmologist’s ability to initiate timely therapies, potentially halting or reversing vision loss before clinical symptoms manifest.

Despite these promises, STOC-T remains an experimental technique, currently limited by technical demands. The system requires cutting-edge hardware, including a high-speed CMOS camera capable of capturing quarter-million frames per second and a tunable near-infrared laser source spanning 800 to 870 nanometers in wavelength. The immense data volume generated—exceeding 8.5 gigabytes per acquisition—also presents significant computational challenges for real-time processing and analysis. These hurdles explain why STOC-T is not yet in widespread clinical use, although ongoing advances in photonic hardware and data science are likely to mitigate these barriers.

Looking forward, the research team envisions enhancing the system’s flexibility using multimode optical fibers for phase modulation. Such fibers, with diameters around 50 micrometers and lengths extending to hundreds of meters, support hundreds of propagation modes. They offer the theoretical potential to reduce optical crosstalk noise by a factor approaching 30 without complex electronic controls, simplifying implementation while preserving image quality improvements.

Professor Wojtkowski emphasizes that STOC-T represents a transformative conceptual advance rather than a final product. The roadmap to widespread application involves optimizing speed, minimizing data volume, refining phase encoding strategies, and automating image reconstruction workflows. The foundational principle—shaping the acquisition process to preempt noise contamination—opens avenues not only for ophthalmology but also for diverse biomedical imaging fields where light scattering impairs image fidelity. This innovation exemplifies how deep physical understanding combined with technical ingenuity can reshape diagnostic imaging, making previously invisible biological details accessible and advancing patient care.

In summary, STOC-T addresses a critical bottleneck in OCT imaging by employing spatio-temporal phase modulation to separate meaningful tissue signals from scattered noise at the data collection stage. This technique enhances resolution, contrast, and functional imaging capability, holding significant promise for earlier and more accurate diagnosis of a broad spectrum of vision-threatening diseases. Although currently laboratory-bound due to technical demands, STOC-T’s theoretical and experimental foundations herald a new era in optical imaging, where noise is never blindly accepted but actively prevented from degrading our view of living tissue.

---

Subject of Research: Human tissue samples

Article Title: Spatio-temporal optical coherence imaging and tomography for in vivo applications

News Publication Date: 25-May-2026

Web References: DOI: 10.1117/1.JBO.31.11.113504

Image Credits: Optica

Keywords

Optical coherence tomography, STOC-T, ophthalmology, retinal imaging, optical crosstalk, phase modulation, optoretinography, photoreceptors, biomedical optics, imaging noise reduction, high-resolution microscopy, optical imaging innovations

In a groundbreaking development poised to redefine waste management and sustainable energy production, researchers have unveiled a revolutionary method for photoreforming solid waste on an unprecedented 1-square-meter scale. This innovative advance, detailed in the latest issue of Nature Chemical Engineering, leverages single-source precursor-derived co-catalyst films to convert ubiquitous solid waste into valuable chemical fuels, heralding a new era in environmental remediation coupled with renewable energy generation.

At the heart of this innovation lies the principle of photoreforming, a process by which sunlight catalyzes the chemical transformation of organic materials into hydrogen and other energy-rich molecules. Historically limited to small-scale demonstrations and powdered catalysts, this method struggled with scalability and practical application outside controlled laboratory settings. The reported technique shatters these limitations by fabricating robust co-catalyst films derived from a unified precursor source, enabling efficient photoconversion across large surface areas with enhanced stability and performance.

The researchers crafted these functional films through an ingenious synthesis route, where a single molecular precursor simultaneously yields both the active catalytic sites and the supporting matrix. This contrasts with conventional multi-step fabrication approaches that often result in inconsistent catalyst dispersion and energy losses. By integrating the catalyst components at the molecular level, the team ensured homogeneity, maximized photon absorption, and optimized charge separation dynamics, all critical parameters for sustained photocatalytic activity.

Transforming real-world solid waste – encompassing plastics, biomass residues, and mixed refuse – into clean fuels presents a formidable challenge due to their complex chemical compositions and structural heterogeneity. The co-catalyst films demonstrated remarkable versatility and adaptability, efficiently processing these diverse substrates under simulated sunlight without requiring extensive pre-treatment. This robustness signals a significant leap toward practical deployment in municipal waste processing facilities and industrial settings.

The experimental setup encompassed a square meter of coated substrate exposed to controlled illumination, mirroring natural sunlight intensity conditions. Over extended operation, the system consistently yielded high rates of hydrogen and other value-added chemicals, outperforming benchmark photocatalysts by a considerable margin. Importantly, the films manifested remarkable photostability and mechanical adhesion, demonstrating resilience against degradation mechanisms like photo-corrosion and mechanical abrasion that typically afflict photocatalytic layers.

At the nanoscale, characterization techniques revealed uniform distribution of nanosized catalytic domains embedded within a conductive, photoactive matrix. This architecture ensures rapid electron-hole separation and transport, minimizing recombination losses which commonly plague photocatalytic systems and limit hydrogen evolution rates. Spectroscopic analyses corroborated enhanced visible-light absorption, attributed to tailored bandgap engineering achieved during precursor design, broadening the usable solar spectrum beyond ultraviolet wavelengths.

The process design also embraced mass transport optimization, incorporating porous film structures that facilitated effective diffusion of reactants and removal of gaseous products. This morphologic control prevented stagnation zones and concentration gradients, enhancing catalytic turnover and ensuring stable long-term performance. Additionally, the modular film fabrication approach promises scalability and integration into various reactor geometries without compromising catalytic efficiency.

Beyond hydrogen generation, the system also showcased the capacity to produce liquid fuels and chemical feedstocks, capitalizing on selective reaction pathways induced by co-catalyst composition tuning. This selectivity allows tailored conversion routes matching industrial chemical demands, moving beyond mere waste disposal toward circular chemical economies. The dual benefit of environmental waste mitigation coupled with clean energy and chemical synthesis embodies transformative potential for sustainable industrial practices.

Critically, the team emphasized the environmental and economic implications of adopting such technology at scale. By converting problematic solid waste streams into valuable resources using sunlight – a free and abundant energy source – this approach diminishes reliance on fossil fuels and reduces landfill burden. Cost analyses suggested that, once scaled, the technique could rival established catalytic processes in operational expenditure, thus offering an attractive proposition for policymakers and industry leaders aiming to meet stringent environmental targets.

The interdisciplinary collaboration instrumental in achieving this advance integrated expertise across materials chemistry, photophysics, environmental engineering, and nanofabrication. Such synthesis of disciplines underscored the inherent complexity of developing scalable photocatalytic platforms capable of handling real-world waste complexities while maintaining high efficiency and durability.

Looking ahead, the researchers are exploring further enhancements including tandem catalyst layers, optimized co-catalyst configurations, and hybrid photochemical-electrochemical systems to elevate the energy conversion efficiency and broaden substrate compatibility. In parallel, pilot-scale demonstrations are underway to validate system performance in outdoor environments subject to variable weather conditions, pivotal for transitioning laboratory innovation into field applications.

This pioneering work sets a new benchmark in photoreforming science, illustrating how precise molecular engineering and thoughtful system design can transform a pressing global challenge—solid waste accumulation—into a renewable energy opportunity. Its implications resonate strongly with global sustainability aspirations, promising an economically feasible and environmentally benign pathway to simultaneously address climate change mitigation, waste reduction, and clean energy production.

As society grapples with mounting waste generation paired with escalating energy demands, innovations such as these underscore the invaluable role of scientific ingenuity in crafting solutions that are as elegant as they are practical. By harnessing the synergy of sunlight and advanced material chemistry, the future of waste management is illuminated—not as a burden, but as a wellspring of renewable chemical energy.

In summary, this major scientific milestone demonstrates that photoreforming solid waste at a 1 m² scale using single-source precursor-derived co-catalyst films is no longer a theoretical possibility but a tangible technological reality. It unequivocally paves the way for deploying solar-driven catalytic systems in addressing environmental and energy crises through smart design and scalable engineering.

Subject of Research:
Photoreforming of solid waste using single-source precursor-derived co-catalyst films.

Article Title:
Photoreforming of solid waste on 1 m² scale using single-source precursor-derived co-catalyst films.

Article References:
Bin Mohamad Annuar, A., Liu, Y., Bhattacharjee, S. et al. Photoreforming of solid waste on 1 m² scale using single-source precursor-derived co-catalyst films. Nat Chem Eng 3, 351–362 (2026). https://doi.org/10.1038/s44286-026-00406-y

Image Credits:
AI Generated

DOI:
10.1038/s44286-026-00406-y

Keywords:
Photoreforming, solid waste conversion, co-catalyst films, solar energy, hydrogen production, photocatalysis, renewable energy, waste-to-fuel, sustainable chemistry, scalable catalysis

A team of researchers at Cornell University has uncovered a surprising problem in a promising class of materials known as hybrid perovskites. The discovery could help scientists build better materials for future technologies, including solar cells, energy-harvesting devices, and advanced electronics. Hybrid perovskites have attracted enormous interest in recent years because they are efficient at […]

The post Scientists discover hidden ‘charge trap’ that could slow next-generation solar and electronic materials appeared first on Knowridge Science Report.

Researchers in South Korea have developed a new type of electronic skin that can be made directly where it is needed, potentially opening the door to smarter robots, advanced wearable devices, and more interactive technologies. Electronic skin, often called e-skin, is a thin and flexible material filled with sensors that can detect pressure, touch, and […]

The post New electronic skin can be made onsite, bringing smarter robots and wearables closer to reality appeared first on Knowridge Science Report.

An ingredient commonly used in ice cream may help scientists transform ordinary dirt into a new generation of environmentally friendly building materials. Researchers at the University of Colorado Boulder have discovered that sodium alginate, a substance made from seaweed and often used to improve the texture of foods, can make natural materials like clay and […]

The post Ice cream ingredient could help turn dirt into 3D-printed homes appeared first on Knowridge Science Report.

In a groundbreaking advancement for cardiovascular science, researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Spain, in collaboration with the Karolinska Institute in Sweden, have devised a cutting-edge technique to analyze the proteome of individual cardiomyocytes. These cells, essential for heart contraction, have long eluded comprehensive single-cell proteomic scrutiny due to technological limitations. This novel approach now allows for a detailed protein-level characterization of single heart muscle cells, opening unprecedented avenues for understanding heart biology and regeneration.

The heart has traditionally been viewed as an organ comprised of relatively homogeneous cardiomyocytes. However, recent findings highlight remarkable heterogeneity even within this single cell type. Variability in protein expression among cardiomyocytes may underpin differences in their functional capacity and regenerative potential. This study, published in Genome Biology, leverages an innovative integration of optimized cell isolation methods, advanced mass spectrometry, and sophisticated bioinformatic algorithms to dissect this proteomic diversity with extraordinary precision.

Central to their investigation was Myc, a transcription factor already noted for its role in regenerative strategies for heart repair. Despite its promise, until now the specific mechanisms by which Myc modulates protein expression in individual cardiomyocytes remained elusive. Applying their novel single-cell proteomics technology, the researchers uncovered that Myc expression differentially alters metabolic enzyme levels across single cardiomyocytes. This heterogeneity results in a subset of cells exhibiting distinct immature states, which in turn possess enhanced regenerative potential—a finding that transforms our comprehension of how cardiac regeneration might be selectively targeted.

The technical feat achieved by these scientists hinges on the fusion of multiple cutting-edge methodologies. First, the meticulous isolation of adult mouse cardiomyocytes ensures viable, intact cells reflecting true physiological states. These cells then undergo mass spectrometry procedures tailored for minute sample volumes, capable of identifying thousands of proteins with high sensitivity and quantitative accuracy at the single-cell level. The ensuing data are processed with bespoke computational pipelines designed to handle the intrinsic variability and noise characteristic of single-cell omics measurements.

By revealing the proteomic fingerprints that distinguish a pro-regenerative subpopulation of cardiomyocytes, this research elucidates a previously uncharted layer of cardiac cellular complexity. Understanding how Myc drives metabolic remodeling at the protein level provides a molecular explanation for its regenerative effects and establishes a foundation for engineering therapeutic approaches that harness or mimic these cellular states.

Regeneration in the adult mammalian heart remains a formidable challenge, owing largely to the low intrinsic capacity of cardiomyocytes to proliferate or replace damaged tissue after injury such as myocardial infarction. Previous models relying largely on bulk tissue analyses have masked the nuanced cellular dynamics at play. This single-cell approach offers resolution sufficient to detect rare but critical cell subsets that might hold the key to effective myocardial repair.

Moreover, this study underscores the transformative impact of integrating proteomics with single-cell biology, moving beyond transcriptomic analyses that often fail to predict functional protein abundance accurately. Proteins, as the primary effectors of cellular function, are the crucial link between gene regulation and phenotype. Hence, this proteomic lens provides a direct readout of the biochemical state of cardiomyocytes under regenerative cues.

The implications of this work extend beyond cardiac biology. It exemplifies the broader potential of single-cell proteomics to deepen our grasp of cellular heterogeneity in health and disease, from cancer biology to neurodegeneration. The refinement and dissemination of such methodologies will empower researchers across biomedical fields to uncover subtle but impactful cellular states previously hidden in ensemble measurements.

Miguel Torres and Jesús Vázquez, who co-led the CNIC teams responsible for this study, emphasize the critical novel insights gained. According to them, dissecting Myc’s action at the single-cell level illuminates pathways and protein networks that govern cellular immaturity and regeneration, which are masked in population-level studies. This knowledge fundamentally shifts how regenerative medicine strategies might be designed, focusing on targeted modulation of key proteins identified within pro-regenerative cardiomyocyte subgroups.

Consuelo Marín-Vicente, the study’s first author, highlights the heterogeneous response to Myc induction in adult cardiomyocytes. Instead of a uniform effect, Myc induces diverse proteomic profiles, driving some cells toward a state primed for regeneration. This discovery points to the existence of intrinsic regulatory mechanisms that govern cardiomyocyte plasticity, with possible manipulation routes to expand these favorable subpopulations therapeutically.

This advancement also signifies a leap toward personalized regenerative therapies. By characterizing the protein signatures specific to regenerative-competent cardiomyocytes, future interventions could selectively enhance these signatures in patient hearts, enabling more effective recovery post-injury. It also offers biomarkers to monitor therapeutic efficacy or to stratify patients likely to benefit from Myc-based or related regenerative treatments.

The CNIC, recognized as a Severo Ochoa Center of Excellence and funded by a unique public-private partnership, remains at the forefront of cardiovascular research. Under the leadership of Dr. Valentín Fuster, CNIC’s mission to translate scientific discoveries into clinical innovations is exemplified by this study’s promise. Collaboration with leading international centers like the Karolinska Institute further underscores the global effort to unravel heart regeneration’s complexity.

In sum, by pioneering a technique for single-cell proteomic analysis of adult cardiomyocytes, this research opens transformative possibilities for cardiovascular medicine. It elucidates how transcription factors like Myc can orchestrate heterogeneous proteomic landscapes within single cells, generating subpopulations equipped with regenerative capabilities. These insights herald a new era in designing precision therapies that could one day restore heart function after injury, dramatically improving outcomes for millions suffering from cardiovascular diseases worldwide.

---

Subject of Research: Cells

Article Title: Pro-regenerative fingerprints identified in a sub-population of adult mouse cardiomyocytes by integrative single-cell proteomics

News Publication Date: 22-May-2026

Web References:
10.1186/s13059-026-04110-1

Image Credits: CNIC

Keywords

Cardiomyocytes, Single-cell proteomics, Myc transcription factor, Heart regeneration, Mass spectrometry, Cellular heterogeneity, Cardiovascular disease, Protein expression, Regenerative medicine, Proteome, Metabolic enzymes, Cardiovascular research

As soon as August, a giant silver bullet will cut its way through the dry air of the southwestern US and cross the Pacific to reach the coast of Japan. 

Once there, the roughly 200-foot-long craft, built by the New Mexico–based company Sceye, will park some 18 kilometers above the ocean’s surface, in a wispy-thin layer known as the stratosphere. Then it will use a custom-built antenna to supplement Softbank’s 5G network, a test that will include beaming data straight to devices. 

Sceye (pronounced “sky”) is one of several firms building a class of airborne craft called HAPS, or high-altitude platform stations or systems. Such a platform can be a plane or a balloon or, yes, an oblong craft filled with helium and outfitted with solar panels. HAPS companies, including the Airbus subsidiary Aalto, envision them serving a variety of lofty purposes, such as delivering internet service to disaster sites and observing Earth’s surface. 

The stratosphere is a good place to be if you want to cover a large area. It’s also much closer to the ground than even the lowest-orbiting satellites, which means sending down a signal takes far less energy. “What we ultimately offer is space-like conditions, without the cost of going to space and without the complexity of being in orbit,” says Mikkel Vestergaard Frandsen, Sceye’s CEO and founder.

But it’s also not so easy to stay there. Sceye’s aircraft, Frandsen says, has to be light enough to stay aloft but also strong enough to carry the necessary systems. It must soak up and store enough solar energy during the day to provide around-the-clock power to an electric fan that can maneuver the HAPS back into place when winds knock it out of position—mettle it proved in a 2024 test flight.

Since then, Sceye has been preparing for its big Japan test. In the flight pictured here from this spring, for example, the craft stayed aloft for 12 days as it flew to the coast of Brazil and spent more than 88 hours “parked” in various locations. Eventually, the company expects its platform could help satellite operators better serve densely populated areas.

Someday, Frandsen says, spotting a HAPS may be as common as seeing ships at port or trains on the tracks.

Electrostatic forces enable low-voltage actuation without relying on rare earth materials. Nearly every electric motor in modern life, from the fan on your desk to the motor in an electric vehicle, relies on magnetism. For more than a century, magnetic fields have dominated motor design because electrostatic forces were considered too weak for practical machines. [...]

When a building inspector takes a photo of a cracked wall, a leaking pipe or a faulty ceiling panel, that image carries almost no information about where exactly it was taken. There's no GPS signal indoors, and manually recording locations is slow, error-prone and easily forgotten. As a result, thousands of inspection photos sit in folders with no spatial context, making it hard to track problems over time or link them to the correct part of a building's maintenance records.

Korean researchers have secured flexible electronic skin technology that can be fabricated directly in the field. This achievement has increased the feasibility of commercializing electronic skin for use in various fields, including robots and wearable devices.